Related Experiment Video
Updated: Jul 9, 2026

Visualization and Quantitative Analysis of Embryonic Angiogenesis in Xenopus tropicalis
Published on: May 25, 2017
Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis
Romeo Ricci1, Grzegorz Sumara, Izabela Sumara
1Cardiovascular Research, Institute of Physiology, and Division of Cardiology, University Hospital Zurich, CH-8057 Zurich, Switzerland. romeo.ricci@cell.biol.ethz.ca
Abstract:
In vitro studies suggest a role for c-Jun N-terminal kinases (JNKs) in proatherogenic cellular processes. We show that atherosclerosis-prone ApoE-/- mice simultaneously lacking JNK2 (ApoE-/- JNK2-/- mice), but not ApoE-/- JNK1-/- mice, developed less atherosclerosis than do ApoE-/- mice. Pharmacological inhibition of JNK activity efficiently reduced plaque formation. Macrophages lacking JNK2 displayed suppressed foam cell formation caused by defective uptake and degradation of modified lipoproteins and showed increased amounts of the modified lipoprotein-binding and -internalizing scavenger receptor A (SR-A), whose phosphorylation was markedly decreased. Macrophage-restricted deletion of JNK2 was sufficient to decrease atherogenesis. Thus, JNK2-dependent phosphorylation of SR-A promotes uptake of lipids in macrophages, thereby regulating foam cell formation, a critical step in atherogenesis.
Insights
c-Jun N-terminal kinases (JNKs) play a role in atherosclerosis. JNK2 deficiency in mice reduced plaque formation by affecting lipid uptake in macrophages, highlighting JNK2 as a potential therapeutic target for atherosclerosis.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Immunology
Background:
- In vitro studies implicate c-Jun N-terminal kinases (JNKs) in cellular processes contributing to atherosclerosis.
- Atherosclerosis is a complex inflammatory disease characterized by plaque buildup in arteries.
Purpose of the Study:
- To investigate the specific roles of JNK1 and JNK2 in the development of atherosclerosis.
- To determine the molecular mechanisms by which JNKs regulate macrophage function in atherogenesis.
Main Methods:
- Utilized apolipoprotein E-deficient (ApoE-/-) mice lacking JNK1 or JNK2.
- Administered pharmacological JNK inhibitors.
- Examined macrophage foam cell formation and scavenger receptor A (SR-A) expression and phosphorylation.
- Performed macrophage-specific JNK2 deletion studies.
Main Results:
- ApoE-/- mice lacking JNK2, but not JNK1, exhibited significantly reduced atherosclerosis.
- Pharmacological JNK inhibition effectively decreased atherosclerotic plaque formation.
- Macrophages deficient in JNK2 showed impaired foam cell formation due to defective modified lipoprotein handling.
- JNK2 deficiency led to increased scavenger receptor A (SR-A) levels and decreased its phosphorylation.
- Macrophage-specific JNK2 deletion was sufficient to attenuate atherogenesis.
Conclusions:
- JNK2, but not JNK1, plays a critical role in promoting atherosclerosis.
- JNK2-dependent phosphorylation of SR-A is essential for lipid uptake by macrophages, driving foam cell formation.
- Targeting JNK2 offers a potential therapeutic strategy for reducing atherosclerosis progression.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Cell Motility through Blebbing
Blebbing Through the Matrix
In multicellular...
Mechanism of Angiogenesis
Regulation of Angiogenesis and Blood Supply
The JAK-STAT Signaling Pathway
Overview of Cell-Matrix Interactions

